[Translation] A single-center, randomized, double-blind, placebo-controlled clinical trial to evaluate the ocular and systemic safety, tolerability, pharmacokinetic and pharmacodynamic characteristics of single and multiple DA001 eye drops in healthy subjects with increasing doses
主要目的:
评估健康受试者单次和连续7天多次DA001滴眼液眼部给药的眼局部和全身安全性和耐受性。
次要目的:
评估健康受试者单次和连续7天多次DA001滴眼液眼部给药的眼局部和全身药代动力学(PK)、药效学(PD)特征。
[Translation] Primary objective:
To evaluate the ocular and systemic safety and tolerability of single and multiple 7-day ocular administration of DA001 eye drops in healthy subjects.
Secondary objective:
To evaluate the ocular and systemic pharmacokinetic (PK) and pharmacodynamic (PD) characteristics of single and multiple 7-day ocular administration of DA001 eye drops in healthy subjects.